Related references
Note: Only part of the references are listed.Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
Patsy S. H. Soon et al.
ENDOCRINE-RELATED CANCER (2013)
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+breast cancer
X. He et al.
ANNALS OF ONCOLOGY (2012)
Diabetes and breast cancer risk: a meta-analysis
P. Boyle et al.
BRITISH JOURNAL OF CANCER (2012)
Insulinemia and the risk of breast cancer and its relapse
V. Formica et al.
DIABETES OBESITY & METABOLISM (2012)
Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes
Rosalyn D. Ferguson et al.
BREAST CANCER RESEARCH (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study
Melinda L. Irwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Catherine Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Kimberly S. Peairs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Oncogene Activation Induces Metabolic Transformation Resulting in Insulin-Independence in Human Breast Cancer Cells
Aliccia Bollig-Fischer et al.
PLOS ONE (2011)
Altered Expression of Insulin Receptor Isoforms in Breast Cancer
Jiaqi Huang et al.
PLOS ONE (2011)
Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes
Ruslan Novosyadlyy et al.
CANCER RESEARCH (2010)
Hyperinsulinemia and type 2 diabetes Impact on cancer
Ruslan Novosyadlyy et al.
CELL CYCLE (2010)
CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer
Jose Baselga et al.
CLINICAL BREAST CANCER (2010)
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes-Mediated Mammary Tumor Progression
Yvonne Fierz et al.
DIABETES (2010)
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
H. Zhang et al.
ONCOGENE (2010)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
Quanri Jin et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Paola Pisani
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Timeline - Insights from transgenic mouse models of ERBB2-induced breast cancer
Josie Ursini-Siegel et al.
NATURE REVIEWS CANCER (2007)
Modulation of mammary tumor development in Tg.NK (MMTV/c-neu) mice by dietary fatty acids and life stage-specific exposure to phytoestrogens
Mirjam Luijten et al.
REPRODUCTIVE TOXICOLOGY (2007)
Vimentin and epithelial-mesenchymal transition in human breast cancer - Observations in vitro and in vivo
Maria I. Kokkinos et al.
CELLS TISSUES ORGANS (2007)
Identification of fibroblast heterogeneity in the tumor microenvironment
Hikaru Sugimoto et al.
CANCER BIOLOGY & THERAPY (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
The origin of vimentin expression in invasive breast cancer:: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?
E Korsching et al.
JOURNAL OF PATHOLOGY (2005)
Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody
D Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis
SE Moody et al.
CANCER CELL (2002)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)
YH Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Clinicopathological study of early adenocarcinoma of the gastric cardia: Comparison with early adenocarcinoma of the distal stomach and esophagus
Y Tajima et al.
ONCOLOGY (2001)
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
D Harari et al.
ONCOGENE (2000)
Share Paper
